Transforming breath into early upper GI cancer detection
Born out of unmet clinical need, built with cutting-edge technology and guided by patient voices. Nasalyzer is developing a breathalyzer to detect gastric cancer non-invasively. Our vision is a world where non-invasive cancer detection is accessible to everyone, everywhere.
Supported by leading institutions
A Clinical Support Tool for Early Detection
Nasalyzer’s breathalyzer detects distinct biomarker patterns in exhaled breath associated with gastric cancer. Using machine learning classifiers, it accurately identifies at-risk breath profiles. The compact device is designed for seamless integration into GP clinics and community healthcare settings.
NON - INVASIVE
Needle-free. Just a breath sample.
IMMEDIATE RESULTS
Results during consultation – not weeks later.
EASY TO USE
Designed for routine GP workflows.
Breath - Smell - Detect
Step 1: Sample
Patients provide a breath sample using our specialized breath collection device.
Step 2: Analysis
The system detects patterns of cancer-associated breath biomarkers in the sample.
Step 3: Results
AI-powered analysis processes the data and delivers results within minutes.
OUR MISSION
NEWSLETTER
Subscribe to receive insights straight to your inbox